Trial
NCT05201794
A Study of JNJ-64281802 for the Prevention of Dengue Infection
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Janssen Research & Development, LLC
Collaborators
—
Condition
Dengue
Intervention
JNJ-64281802
Why stopped
The study was stopped due to portfolio reprioritization. This decision is not based on any safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-31